HYALURONIC-ACID VITREOUS SUBSTITUTE - 6-YEAR CLINICAL-EVALUATION

被引：63

作者：

PRUETT, RC ^{[1
]}

SCHEPENS, CL ^{[1
]}

SWANN, DA ^{[1
]}

机构：

[1] SHRINERS BURNS INST,BOSTON,MA

来源：

ARCHIVES OF OPHTHALMOLOGY | 1979年 / 97卷 / 12期

关键词：

D O I：

10.1001/archopht.1979.01020020541006

中图分类号：

R77 [眼科学];

学科分类号：

100212 ;

摘要：

Hyaluronic acid vitreous substitute (HYVISC) was used during 347 operations performed on 294 eyes of 286 patients. It was injected intraocularly in 266 operations (73 scleral bucklings, 175 open-sky vitrectomies, among others) on eyes with complex retinal detachments that were considered inoperable by ordinary surgical techniques. During 81 closed vitrectomies, it was applied extraocularly between the surgical contact lens and the cornea. Hyaluronic acid was found to be well tolerated by human eyes. In eyes that had been given a poor prognosis, scleral buckling with hyaluronic acid tamponade produced reattachment in 16% of the eyes; open-sky vitrectomy, scleral buckling, and hyaluronic acid salvaged 18%. It also appeared helpful in the preservation of corneal epithelial integrity and clarity during closed vitrectomy. © 1979, American Medical Association. All rights reserved.

引用

页码：2325 / 2330

页数：6

共 7 条

[1]

BALAZS EA, 1976, ADV VITREOUS SURGERY, P601

[2] BIOLOGICAL VITREOUS SUBSTITUTES - INFLAMMATORY RESPONSE IN NORMAL AND ALTERED ANIMAL EYES [J].